The reporting is weird but no dose response evident in log HBsAg reduction. Haven't we seen similar (if not better) results over the years that don't pan out?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.